Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A Second Opinion Could Help Curb Wasteful Healthcare Spending in the US

On today’s episode of the MarketScale Healthcare podcast, Voice of B2B Daniel Litwin explores waste in the American healthcare system. A recent October 2019 study in JAMA by Dr. William Shrank showed waste makes up almost a quarter, or 25%, of U.S. healthcare spending, which, when quantified, can reach $935 billion by some estimates….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
A Second Opinion Could Help Curb Wasteful Healthcare Spending in the US

On today’s episode of the MarketScale Healthcare podcast, Voice of B2B Daniel Litwin explores waste in the American healthcare system.

A recent October 2019 study in JAMA by Dr. William Shrank showed waste makes up almost a quarter, or 25%, of U.S. healthcare spending, which, when quantified, can reach $935 billion by some estimates.

How does this impact the system as a whole? What are some potential solutions? We’re spoke to both of those major questions today with Jason Melton, CEO of 2nd.MD, who’s looking to combat waste in our healthcare system through medtech.

Specializing in medical certainty, 2nd.MD connects patients to a network of hundreds of expert physicians ready to give a second opinion on their diagnosis and treatment plan, with the goal being to create an optimum treatment plan from the beginning to significantly improve outcomes and reduce ineffective or unnecessary medical spend.

Melton and Litwin spend the podcast breaking down…

  • How 30% of healthcare costs are wasted on unnecessary or incorrect care
  • How wasteful spending fits into the broader dynamic of overspending in American healthcare
  • The financial and health effects of incorrect care on physicians and patients
  • Where a medtech solution fits into the mission to curb wasteful care spending
  • How 2nd.MD created and expanded their network of physicians

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

The global structural health monitoring (SHM) market is projected to surpass $8.6 billion by 2035. This growth is fueled by the integration of AI analytics, wireless sensor technologies, and the necessity to address aging infrastructure. The expansion reflects a widespread adoption of these technologies in various sectors.

  • 01The SHM market is expected to exceed $8.6 billion by 2035.
  • 02Advancements in AI-powered analytics and wireless sensors are key drivers of market growth.
  • 03Aging infrastructure is creating a demand for enhanced structural health monitoring solutions.

Jul 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512